Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 4 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
ASO Author Reflections: Opting for a Cost-Effective Treatment Allocation in Patients with Esophageal Cancer.
Ann Surg Oncol. 2022 Jun;29(6):3654-3655. doi: 10.1245/s10434-021-11230-4. Epub 2022 Jan 13.
Ann Surg Oncol. 2022.
PMID: 35024994
No abstract available.
Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance.
Graham Martinez C, Kus Öztürk S, Al-Kaabi A, Valkema MJ, Bokhorst JM, Rosman C, Rütten H, Wauters CAP, Doukas M, van Lanschot JJ, Siersema PD, Nagtegaal ID, van der Post RS.
Graham Martinez C, et al. Among authors: van lanschot jj.
Histopathology. 2022 May;80(6):982-994. doi: 10.1111/his.14644. Epub 2022 Apr 6.
Histopathology. 2022.
PMID: 35352847
Free PMC article.
Item in Clipboard
Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study.
Gao X, Tsai PC, Chuang KH, Pai CP, Hsu PK, Li SH, Lu HI, van Lanschot JJ, Chao YK.
Gao X, et al. Among authors: van lanschot jj.
Cancers (Basel). 2022 May 25;14(11):2610. doi: 10.3390/cancers14112610.
Cancers (Basel). 2022.
PMID: 35681592
Free PMC article.
Item in Clipboard
Treatment burden and cost-effectiveness analysis of the neoadjuvant CROSS regimen in esophageal squamous cell carcinoma: a multicenter retrospective study.
Gao X, Yang ZH, Cheng YH, Chi CL, Yang TY, Chuang KH, Wu CE, van Lanschot JJ, Wen YW, Chao YK.
Gao X, et al. Among authors: van lanschot jj.
Dis Esophagus. 2023 Oct 27;36(11):doad031. doi: 10.1093/dote/doad031.
Dis Esophagus. 2023.
PMID: 37236810
Item in Clipboard
Neoadjuvant Therapy Versus Upfront Surgery for Patients With Clinical Stage 2 or 3 Esophageal Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Gao X, Wen YW, van Lanschot JJB, Chao YK.
Gao X, et al. Among authors: van lanschot jjb.
Ann Surg Oncol. 2022 Jun;29(6):3644-3653. doi: 10.1245/s10434-021-11207-3. Epub 2022 Jan 11.
Ann Surg Oncol. 2022.
PMID: 35018592
Item in Clipboard
Cite
Cite